BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Allergy to pollen
,
Lymphocyte
,
Human chorionic gonadotropin
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Apatinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
TRIM31
HSPA6
CYP26A1
ANXA10
ABCA1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
HAY_BONE_MARROW_ERYTHROBLAST
TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL
PUJANA_BRCA1_PCC_NETWORK
TIEN_INTESTINE_PROBIOTICS_24HR_UP
TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer PC9 cells gefitinib-sensitive or resistant cells treated with apatinib
Explore Curated Studies Results
Literature
Most Relevant Literature
Nano-composite hydrogels of Cu-Apa micelles for anti-vasculogenic mimicry.
Efficacy and safety of apatinib and transcatheter arterial chemoembolization as second-line therapy …
Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma.
Efficacy, Safety, and Biomarker Analysis of Neoadjuvant Camrelizumab and Apatinib in Patients With R…
Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gast…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Apatinib for Metastatic Esophageal Cancer.
Camrelizumab Combined With Apatinib Mesylate
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
A Clinical Trial With Apatinib for Subjects With Refractory Malignant Ascites
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ